A pilot study to determine the safety and efficacy of induction-therapy, de novo MPA and delayed mTOR-inhibition in liver transplant recipients with impaired renal function. (PATRON-Study).
Phase of Trial: Phase III
Latest Information Update: 01 Sep 2012
At a glance
- Drugs Basiliximab (Primary) ; Daclizumab (Primary) ; Mycophenolate mofetil (Primary) ; Sirolimus (Primary) ; Corticosteroids; Mycophenolate mofetil; Prednisolone
- Indications Liver transplant rejection
- Focus Therapeutic Use
- Acronyms PATRON
- 31 Aug 2018 Biomarkers information updated
- 01 Sep 2012 Status changed from recruiting to completed., according to European Clinical Trials database.
- 01 Sep 2012 Additional trial source identified from European clinical trials database and integrated (EudraCT2007-003561-40)